Enhancing T-cell infiltration into glioblastoma (GBM) tumors has proven challenging yet remains crucial for improving the efficacy of immunotherapy for patients with this deadly cancer. In this issue, Qin, Huang, Li, and colleagues find that inhibiting vasculature formation driven by cancer stem cells is a promising target to enhance immunotherapy in GBM. See related article by Qin, Huang, Li, et al., p. 1351 (2).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2326-6066.CIR-23-0667 | DOI Listing |
Publication Analysis
Top Keywords
immunotherapy gbm
8
qin huang
8
guard camp
4
camp activators
4
activators improve
4
improve immunotherapy
4
gbm enhancing
4
enhancing t-cell
4
t-cell infiltration
4
infiltration glioblastoma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!